Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Rodeheffer

Showing results (61-70 of 118) with videos related to

Pageof 12
Sort By:
Journal of the American College of Cardiology|August 29, 2009
Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathyKatharine M Brauch, Margaret L Karst, Kathleen J Herron, et al.
Circulation|April 4, 2007
Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, MinnesotaCarolyn S P Lam, Véronique L Roger, Richard J Rodeheffer, et al.
JAMA|August 25, 2011
Progression of left ventricular diastolic dysfunction and risk of heart failureGarvan C Kane, Barry L Karon, Douglas W Mahoney, et al.
Journal of the American Heart Association|December 25, 2015
Aldosterone Predicts Cardiovascular, Renal, and Metabolic Disease in the General Community: A 4-Year Follow-UpAlessia Buglioni, Valentina Cannone, S Jeson Sangaralingham, et al.
European Heart Journal|May 31, 2012
Diastolic stiffness as assessed by diastolic wall strain is associated with adverse remodelling and poor outcomes in heart failure with preserved ejection fractionTomohito Ohtani, Selma F Mohammed, Kazuhiro Yamamoto, et al.
Mayo Clinic Proceedings|December 3, 2011
Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: a 9-year follow-up studyPaul M McKie, Alessandro Cataliotti, S Jeson Sangaralingham, et al.
Arthritis Care & Research|January 13, 2011
Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular diseaseCynthia S Crowson, Elena Myasoedova, John M Davis, et al.
The Journal of Rheumatology|October 19, 2010
Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular diseaseCynthia S Crowson, Elena Myasoedova, John M Davis, et al.
American Heart Journal|August 30, 2003
Prognostic implications of ejection fraction from linear echocardiographic dimensions: the Strong Heart StudyRichard B Devereux, Mary J Roman, Vittorio Palmieri, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 19, 2007
Systemic inflammation and metabolic syndrome in cardiac allograft vasculopathyEugenia R Raichlin, Joseph P McConnell, Amir Lerman, et al.
Pageof 12

Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
Journal of the American College of Cardiology|August 29, 2009
Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathyKatharine M Brauch, Margaret L Karst, Kathleen J Herron, et al.
Circulation|April 4, 2007
Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, MinnesotaCarolyn S P Lam, Véronique L Roger, Richard J Rodeheffer, et al.
JAMA|August 25, 2011
Progression of left ventricular diastolic dysfunction and risk of heart failureGarvan C Kane, Barry L Karon, Douglas W Mahoney, et al.
Journal of the American Heart Association|December 25, 2015
Aldosterone Predicts Cardiovascular, Renal, and Metabolic Disease in the General Community: A 4-Year Follow-UpAlessia Buglioni, Valentina Cannone, S Jeson Sangaralingham, et al.
European Heart Journal|May 31, 2012
Diastolic stiffness as assessed by diastolic wall strain is associated with adverse remodelling and poor outcomes in heart failure with preserved ejection fractionTomohito Ohtani, Selma F Mohammed, Kazuhiro Yamamoto, et al.
Mayo Clinic Proceedings|December 3, 2011
Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: a 9-year follow-up studyPaul M McKie, Alessandro Cataliotti, S Jeson Sangaralingham, et al.
Arthritis Care & Research|January 13, 2011
Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular diseaseCynthia S Crowson, Elena Myasoedova, John M Davis, et al.
The Journal of Rheumatology|October 19, 2010
Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular diseaseCynthia S Crowson, Elena Myasoedova, John M Davis, et al.
American Heart Journal|August 30, 2003
Prognostic implications of ejection fraction from linear echocardiographic dimensions: the Strong Heart StudyRichard B Devereux, Mary J Roman, Vittorio Palmieri, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 19, 2007
Systemic inflammation and metabolic syndrome in cardiac allograft vasculopathyEugenia R Raichlin, Joseph P McConnell, Amir Lerman, et al.
Pageof 12